Paulo Gustavo Bergerot

Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

Nazlı Dizman, Luís Meza, Paulo Gustavo Bergerot et al. · Nature Medicine · 2022 · 427 citations · Full text

Stool Microbiome Profiling of Patients with Metastatic Renal Cell Carcinoma Receiving Anti–PD-1 Immune Checkpoint Inhibitors

Nicholas Salgia, Paulo Gustavo Bergerot, Manuel Caitano Maia et al. · European Urology · 2020 · 181 citations

Dysbiosis, Stool Microbiome Profiling, Cancer Immunosurveillance +6

Fear of Cancer Recurrence or Progression: What Is It and What Can We Do About It?

Cristiane Decat Bergerot, Errol J. Philip, Paulo Gustavo Bergerot et al. · American Society of Clinical Oncology Educational Book · 2022 · 75 citations · Full text

Cancer Pathology, Cancer Trajectory, Cancer Management +16

Correlates of clinical benefit from immunotherapy and targeted therapy in metastatic renal cell carcinoma: comprehensive genomic and transcriptomic analysis

Nazlı Dizman, Yung Lyou, Nicholas Salgia et al. · Journal for ImmunoTherapy of Cancer · 2020 · 73 citations · Full text

Randomized trial assessing impact of probiotic supplementation on gut microbiome and clinical outcome from targeted therapy in metastatic renal cell carcinoma

Nazlı Dizman, Joann Hsu, Paulo Gustavo Bergerot et al. · Cancer Medicine · 2020 · 73 citations · Full text

Dysbiosis, Pathology, Probiotics +21